Search


USFDA Guidances: Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment, Other Quality-Related Considerations & Classification Categories for Certain Supplements
In 08 September 2025, the U.S. Food and Drug Administration (FDA) issued two final guidances addressing critical aspects of biosimilar...

Sharan Murugan
Sep 92 min read
Â
Â
